An acquisition, an ad campaign, and promising trial results, let's go over the stories we've been watching, commenting on, and in some cases, trading, this week.
Questcor is being acquired by Mallinckrodt for $5.6 billion. Read the article for details.
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Ironwood is starting TV ads for Linzess. Read the article to find out how this should affect sales over time.
Merck reported positive Hepatitis C trial results. Read the article for details on which genotypes were helped and how this stacks up with the new gold-standard for HCV treatment.